Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Patient Monitoring

PUBLISHER: Grand View Research | PRODUCT CODE: 1571566

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1571566

Immunoprecipitation Market Size, Share & Trends Analysis Report By Product (Kits, Reagents), By Type, By End-use (Academic & Research Institutes, Pharma & Biotech Companies, CROs), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

Immunoprecipitation Market Growth & Trends:

The global immunoprecipitation market size is anticipated to reach USD 1.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.7% from 2024 to 2030. Growth of the life science sector is expected to drive the market. Technological advancements in immunoprecipitation techniques is another factor contributing to high demand.

Immunoprecipitation helps precipitate target protein from a solution by binding an antibody to that protein. This technique allows isolation and concentration of a particular protein or protein complex out of a sample of numerous different proteins. Growth in the life science industry is rising mainly due to significant investments made in the R&D sector by key players. In 2016, Merck invested around USD 286.8 million in R&D, which supported their launch of over 2,000 products.

Introduction of novel products in protein purification methods has led to rapid growth in the market. For instance, in 2016, Thermo Fisher Scientific introduced a new antibody testing and verification methodology by using Immunoprecipitation-Mass Spectrometry technique. This is developed in order to assist antibody manufacturers, researchers, and other customers in identifying a suitable antibody for protein analysis. Availability of varied kits and reagents, such as antibodies, beads, and buffers is expected to increase the adoption of this technique to a great extent.

Immunoprecipitation Market Report Highlights:

  • The reagents product segment dominated the immunoprecipitation market with a revenue share of 53.9% in 2023. The reagents segment is dominated by antibodies, which are used extensively for various immunoprecipitation techniques.
  • The individual protein immunoprecipitation type segment dominated the immunoprecipitation market with a revenue share of 28.6% in 2023.
  • The academic & research institutes segment dominated the immunoprecipitation market with a revenue share of 45.1% in 2023, fueled by increased R&D investments and funding from government grants, donations, and private organizations.
  • North America immunoprecipitation market dominated the global immunoprecipitation market with a revenue share of 36.7% in 2023.
Show more
Product Code: GVR-4-68038-017-0

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Immunoprecipitation Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Immunoprecipitation Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Immunoprecipitation Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Immunoprecipitation Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Kits
    • 4.3.1. Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Reagents
    • 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Antibodies
      • 4.4.2.1. Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Beads
      • 4.4.3.1. Beads Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Immunoprecipitation Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Immunoprecipitation Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Individual Protein Immunoprecipitation
    • 5.3.1. Individual Protein Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Protein Complex Immunoprecipitation
    • 5.4.1. Protein Complex Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Chromatin Immunoprecipitation
    • 5.5.1. Chromatin Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Ribonucleoprotein Immunoprecipitation
    • 5.6.1. Ribonucleoprotein Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Tagged Proteins Immunoprecipitation
    • 5.7.1. Tagged Proteins Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Immunoprecipitation Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Immunoprecipitation Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Contract Research Organizations
    • 6.5.1. Contract Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Immunoprecipitation Market: Regional Estimates & Trend Analysis

  • 7.1. Immunoprecipitation Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/Strategic Initiatives
    • 8.4.2. Abcam Limited
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/Strategic Initiatives
    • 8.4.3. BioLegend, Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/Strategic Initiatives
    • 8.4.4. Bio-Rad Laboratories, Inc.
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/Strategic Initiatives
    • 8.4.5. GenScript
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/Strategic Initiatives
    • 8.4.6. Merck KGaA
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/Strategic Initiatives
    • 8.4.7. Novus Biologicals
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/Strategic Initiatives
    • 8.4.8. Takara Bio Inc.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/Strategic Initiatives
    • 8.4.9. Biologics International Corp
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/Strategic Initiatives
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!